Roche: CHMP Backs Tecentriq in Extensive-Stage Small-Cell Lung Cancer

Date : 07/26/2019 @ 2:46PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 41.2  -1.19 (-2.81%) @ 9:00PM
After Hours
Last Trade
Last $ 41.20 ◊ 0.00 (0.00%)

Roche: CHMP Backs Tecentriq in Extensive-Stage Small-Cell Lung Cancer

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Roche Holding (QX) Charts.

By Colin Kellaher


Roche Holding AG (ROG.EB) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of the cancer drug Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small-cell lung cancer.

The Swiss drugmaker said the CHMP positive opinion is based on the results from a Phase 3 study that showed the Tecentriq combination significantly improved overall survival and progression-free survival in such patients.

Lung cancer is the leading cause of cancer death worldwide, and small-cell lung cancer accounts for about 15% of all cases, with some 70% of patients diagnosed in the "extensive stage," which often means a poor prognosis, Roche said.

The company said it expects a final decision from the European Commission in the near future. The commission generally follows the CHMP's recommendations.


Write to Colin Kellaher at


(END) Dow Jones Newswires

July 26, 2019 10:31 ET (14:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.